Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications (Q40902829)

24 September 2017

Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications (English)

1 reference

24 September 2017

Chu W

1

1 reference

24 September 2017

Pak BJ

2

1 reference

24 September 2017

Bani MR

3

1 reference

24 September 2017

Kapoor M

4

1 reference

24 September 2017

Lu SJ

5

1 reference

24 September 2017

Tamir A

6

1 reference

24 September 2017

Kerbel RS

7

1 reference

24 September 2017

Ben-David Y

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

24 September 2017

1 reference

24 September 2017

19

1 reference

24 September 2017

3

1 reference

24 September 2017

395-402

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203315

24 September 2017

0 references

cites work

Regulation of mammalian melanogenesis. I: Partial purification and characterization of a dopachrome converting factor: dopachrome tautomerase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Levels of dopachrome tautomerase in human melanocytes cultured in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Medical management of stage IV malignant melanoma. Medical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

The use of melanosomal proteins in the immunotherapy of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Both P-gp and MRP contribute to drug resistance in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

O6-alkylguanine-DNA alkyltransferase activity in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Dopachrome conversion factor functions as an isomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

7 January 2021

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

7 January 2021

Retroviral Mutagenesis of Cellular Oncogenes: A Review with Insights into the Mechanisms of Insertional Activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

7 January 2021

Enhanced DNA repair and resistance to cisplatin in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

7 January 2021

Function of dopachrome oxidoreductase and metal ions in dopachrome conversion in the eumelanin pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203315

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203315

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference